Targeted Drug May Aid Pancreatic Cancer Patients With BRCA Mutation

Under normal circumstances, BRCA keeps tumors at bay by repairing damaged DNA. However, a mutation in BRCA causes it to lose its tumor-suppressing abilities, increasing susceptibility to cancer.